Volume 45, Issue 6 pp. 602-613
ORIGINAL ARTICLE

MiR-96 regulates bone metabolism by targeting osterix

Hua Liu

Hua Liu

Department of Orthopedics, The Xiangya Hospital of Central South University, Changsha, China

Search for more papers by this author
Qing Liu

Qing Liu

Department of Orthopedics, The Xiangya Hospital of Central South University, Changsha, China

Search for more papers by this author
Xian-Ping Wu

Xian-Ping Wu

Institute of Endocrinology & Metabolism, The Second Xiangya Hospital of Central South University, Changsha, China

Search for more papers by this author
Hong-Bo He

Hong-Bo He

Department of Orthopedics, The Xiangya Hospital of Central South University, Changsha, China

Search for more papers by this author
Lei Fu

Corresponding Author

Lei Fu

Department of Infectious Diseases, The Xiangya Hospital of Central South University, Changsha, China

Correspondence

Lei Fu, Department of Infectious Diseases, The Xiangya Hospital of Central South University, Changsha, China.

Email: [email protected]

Search for more papers by this author
First published: 30 December 2017
Citations: 32

Summary

MicroRNAs (miRNAs) play important roles in bone metabolism and aging. Here we show that miR-96 was markedly up-regulated in serum of elderly patients with osteoporosis by miRNA microarray analysis and qRT-PCR. Moreover miR-96 was also up-regulated in bone marrow mesenchymal stem cells (BMSCs) of aged humans and mice. Our results show that the over-expression of miR-96 reduced osteogenic differentiation of BMSCs, whereas the inhibition of miR-96 increased osteogenic differentiation of BMSCs. At the molecular level, miR-96 regulated osteogenesis by targeting osterix. Interestingly, over-expression of miR-96 in young mice by intravenous injection of agomiR-96 developed a low bone mass due to impaired osteogenesis. However, inhibition of miR-96 in aged mice attenuated the age-related bone loss. Thus, our data suggest that miR-96 regulates osteogenesis and may represent a potential diagnostic marker or therapeutic target for age-related bone loss.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.